Global Imbalances in Funding Sources for HIV Randomized Control Trials
- 10 January 2023
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 39 (2), 53-56
- https://doi.org/10.1089/aid.2022.0068
Abstract
Improving access to grant funding is a critical aspect of strengthening research capacity outside of higher income settings, particularly in HIV/AIDS where randomized control trials (RCTs) that require substantial resources are common. In this article, we assessed recent RCTs to examine variation in how studies were funded, depending on study location and the countries where publication authors were based. We conducted a PubMed literature review to identify RCTs with HIV status or viral load endpoints published in 2019 and 2020, then analyzed cross-tabulations of funding sources by study characteristics. One hundred sixteen publications met the inclusion criteria. Research in higher income countries was most likely to be funded by biotech/pharmaceutical companies, whereas research in lower- and middle-income countries was most likely to be funded by U.S. government sources. Overall, we found the distribution of funding sources differed significantly by study and author location (χ2 = 23, p < .001). Published RCTs with HIV status or viral load endpoints are financed differently based on where studies take place and where the authors are based. As part of future research, understanding why this variation exists is critical for assessing how funding contributes to global imbalances in scientific resources.Keywords
This publication has 16 references indexed in Scilit:
- Recruitment of Underrepresented Minority Researchers into HIV Prevention Research: The HIV Prevention Trials Network Scholars ProgramAIDS Research and Human Retroviruses, 2018
- Comparative assessment of five trials of universal HIV testing and treatment in sub‐Saharan AfricaJournal of the International AIDS Society, 2018
- Published randomized trials performed in Sub-Saharan Africa focus on high-burden diseases but are frequently funded and led by high-income countriesJournal of Clinical Epidemiology, 2016
- The history and fate of the gold standardThe Lancet, 2015
- International Scientific Collaboration in HIV and HPV: A Network AnalysisPLOS ONE, 2014
- Pattern and determinants of HIV research productivity in sub-Saharan Africa: bibliometric analysis of 1981 to 2009 PubMed papersBMC Infectious Diseases, 2010
- Eighteen Years of Research on AIDS: Contribution of and Collaborations between Different World RegionsAIDS Research and Human Retroviruses, 2006
- Randomised controlled trials in Africa of HIV and AIDS: descriptive study and spatial distributionBMJ, 2005
- International collaboration, funding and association with burden of disease in randomized controlled trials in Africa.2005
- Strengthening health research capacity in developing countries: a critical element for achieving health equity Commentary: Health research and human development in Papua New Guinea Commentary: Does strengthening research capacity improve health equity?BMJ, 2000